Cargando…
Precision Medicine of Sodium Benzoate for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)
OBJECTIVE: Behavioral and psychological symptoms of dementia (BPSD) are associated with poorer prognosis of dementia. A 24-week study demonstrated that sodium benzoate, a D-amino acid oxidase (DAAO) inhibitor, surpassed placebo in improving cognitive function in early-phase Alzheimer’s disease; howe...
Autores principales: | Lin, Chieh-Hsin, Yang, Hui-Ting, Chen, Ping-Kun, Wang, Shi-Heng, Lane, Hsien-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039065/ https://www.ncbi.nlm.nih.gov/pubmed/32110025 http://dx.doi.org/10.2147/NDT.S234371 |
Ejemplares similares
-
Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia: Secondary Analysis of a Randomized Clinical Trial
por: Lin, Chieh-Hsin, et al.
Publicado: (2021) -
Antipsychotics for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)
por: Liperoti, Rosa, et al.
Publicado: (2008) -
Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics
por: Calsolaro, Valeria, et al.
Publicado: (2021) -
Editorial: Pharmacology of BPSD (Behavioral and Psychological Symptoms of Dementia)
por: Giménez-Llort, Lydia, et al.
Publicado: (2021) -
The Role of N-Methyl-D-Aspartate Receptor Neurotransmission and Precision Medicine in Behavioral and Psychological Symptoms of Dementia
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)